Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.
| Quantity | 500 mg, 1 gram |
|---|
Be the first to review “Ruxolitinib”
Related products
Sale!
*Sales Promotion for 2022
$165.00 – $255.00
New Research Chemicals
$100.00 – $500.00
New Research Chemicals
$135.00 – $500.00
Sale!
*Sales Promotion for 2022
$100.00 – $550.00
*New Arrival
$150.00 – $500.00
Powder for Hairloss Treatment Research
$200.00 – $800.00
Sale!
*New Arrival
$355.00 – $1,980.00
Sale!
Powder for Hairloss Treatment Research
$300.00 – $4,500.00
Reviews
There are no reviews yet.